Li, C.-C., Matthews, A. K., Gao, X., & Cheung, K. (2023). Preliminary Testing of A Web-Based Lung Cancer Screening Decision Coaching Tool for Older Chinese American Smokers and Their Providers. Journal of the National Medical Association, 115(2), 223–232. https://doi.org/10.1016/j.jnma.2023.01.009

Lee, S. M., Fan, W., Wang, A., Vaidya, R., Redman, M. W., Gettinger, S. N., Bazhenova, L., Herbst, R. S., Hershman, D. L., & Unger, J. M. (2023). Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO Clinical Cancer Informatics, 7. https://doi.org/10.1200/cci.22.00165

Maniar, R., Gallitano, S. M., Husain, S., Moazami, G., Weiss, M. J., & Shu, C. A. (2023). Unusual Adverse Events in a Patient With BRAF-Mutated Non–Small Cell Lung Cancer Treated With BRAF/MEK Inhibition. Journal of the National Comprehensive Cancer Network, 21(3), 232–234. https://doi.org/10.6004/jnccn.2022.7084

Hosseini, M., & Salvatore, M. (2023). Is pulmonary fibrosis a precancerous disease? European Journal of Radiology, 160, 110723. https://doi.org/10.1016/j.ejrad.2023.110723

Steinfort, D. P., Antippa, P., Rangamuwa, K., Irving, L. B., Christie, M., Chan, E., Marinelli, B., Wang, J., Yoneda, K. Y., Raina, S., & Herth, F. J. (2023). Safety and Feasibility of a Novel Externally Cooled Bronchoscopic Radiofrequency Ablation Catheter for Ablation of Peripheral Lung Tumours: A First-In-Human Dose Escalation Study. Respiration, 102(3), 211–219. Portico. https://doi.org/10.1159/000529167

Mamudu, L., Salmeron, B., Odame, E. A., Atandoh, P. H., Reyes, J. L., Whiteside, M., Yang, J., Mamudu, H. M., & Williams, F. (2022). Disparities in localized malignant lung cancer surgical treatment: A population‐based cancer registry analysis. Cancer Medicine, 12(6), 7427–7437. Portico. https://doi.org/10.1002/cam4.5450

Maniar, R., Wang, P. H., Washburn, R. S., Kratchmarov, R., Coley, S. M., Saqi, A., Pan, S. S., Hu, J., Shu, C. A., Rizvi, N. A., Henick, B. S., & Reiner, S. L. (2022). Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy. Cancer Immunology Research, 11(2), 164–170. https://doi.org/10.1158/2326-6066.cir-22-0524

Pan, Y., Han, H., Hu, H., Wang, H., Song, Y., Hao, Y., Tong, X., Patel, A. S., Misirlioglu, S., Tang, S., Huang, H.-Y., Geng, K., Chen, T., Karatza, A., Sherman, F., Labbe, K. E., Yang, F., Chafitz, A., Peng, C., … Wong, K.-K. (2023). KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. Cancer Cell, 41(1), 88-105.e8. https://doi.org/10.1016/j.ccell.2022.11.015

de Castro, G., Rizvi, N. A., Schmid, P., Syrigos, K., Martin, C., Yamamoto, N., Cheng, Y., Moiseyenko, V., Summers, Y., Vynnychenko, I., Lee, S. Y., Bryl, M., Zer, A., Erman, M., Timcheva, C., Raja, R., Naicker, K., Scheuring, U., Walker, J., … Mok, T. (2023). NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC. Journal of Thoracic Oncology, 18(1), 106–119. https://doi.org/10.1016/j.jtho.2022.09.223

Savari, O., Febres‐Aldana, C., Chang, J. C., Fanaroff, R. E., Ventura, K., Bodd, F., Paik, P., Vundavalli, M., Saqi, A., Askin, F. B., Travis, W. D., & Rekhtman, N. (2022). Non‐small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours. Histopathology, 82(2), 242–253. Portico. https://doi.org/10.1111/his.14801

Capaccione, K. M., Huang, S., D’souza, B., Leb, J., Luk, L., Goldstein, J., May, B., Deng, A., & Salvatore, M. M. (2023). Radiographic features of pneumonitis in patients treated with immunotherapy compared to traditional chemotherapy for non-small cell lung cancer. Clinical Imaging, 93, 106–112. https://doi.org/10.1016/j.clinimag.2022.03.006

Shabbir, A., Kojadinovic, A., Shafiq, T., & Mundi, P. S. (2023). Targeting RET alterations in cancer: Recent progress and future directions. Critical Reviews in Oncology/Hematology, 181, 103882. https://doi.org/10.1016/j.critrevonc.2022.103882

Capaccione, K. M., Valiplackal, J. P., Huang, A., Roa, T., Fruauff, A., Liou, C., Kim, E., Khurana, S., Maher, M., Ma, H., Ngyuen, P., Mak, S., Dumeer, S., Lala, S., D’souza, B., Laifer-Narin, S., Desperito, E., Ruzal-Shapiro, C., & Salvatore, M. M. (2022). Checkpoint Inhibitor Immune-Related Adverse Events: A Multimodality Pictorial Review. Academic Radiology, 29(12), 1869–1884. https://doi.org/10.1016/j.acra.2022.03.007

Chaudhary, K. R., Kinslow, C. J., Cheng, H., Silva, J. M., Yu, J., Wang, Tony. J., Hei, T. K., Halmos, B., & Cheng, S. K. (2022). Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-14448-8

Paik, P. K., Luo, J., Ai, N., Kim, R., Ahn, L., Biswas, A., Coker, C., Ma, W., Wong, P., Buonocore, D. J., Lai, W. V., Chaft, J. E., Acharyya, S., Massagué, J., & Kris, M. G. (2022). Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-33719-6

Primakov, S. P., Ibrahim, A., van Timmeren, J. E., Wu, G., Keek, S. A., Beuque, M., Granzier, R. W. Y., Lavrova, E., Scrivener, M., Sanduleanu, S., Kayan, E., Halilaj, I., Lenaers, A., Wu, J., Monshouwer, R., Geets, X., Gietema, H. A., Hendriks, L. E. L., Morin, O., … Lambin, P. (2022). Automated detection and segmentation of non-small cell lung cancer computed tomography images. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-30841-3

Sun, J., Fang, F., Olén, O., Song, M., Halfvarson, J., Roelstraete, B., Khalili, H., & Ludvigsson, J. F. (2022). Normal gastrointestinal mucosa at biopsy and subsequent cancer risk: nationwide population-based, sibling-controlled cohort study. BMC Cancer, 22(1). https://doi.org/10.1186/s12885-022-09992-5

Van Egeren, D., Kohli, K., Warner, J. L., Bedard, P. L., Riely, G., Lepisto, E., Schrag, D., LeNoue-Newton, M., Catalano, P., Kehl, K. L., Michor, F., Fiandalo, M., Foti, M., Khotskaya, Y., Lee, J., Peters, N., Sweeney, S., Abraham, J., … Walther, Z. (2022). Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-21448-1

Sung, S., Heymann, J. J., Politis, M. G., Baine, M. K., Rekhtman, N., & Saqi, A. (2022). Small Biopsy and Cytology of Pulmonary Neuroendocrine Neoplasms: Brief Overview of Classification, Immunohistochemistry, Molecular Profiles, and World Health Organization Updates. Advances in Anatomic Pathology, 29(6), 329–336. https://doi.org/10.1097/pap.0000000000000360

Dimitriou, F., Namikawa, K., Reijers, I. L. M., Buchbinder, E. I., Soon, J. A., Zaremba, A., Teterycz, P., Mooradian, M. J., Armstrong, E., Nakamura, Y., Vitale, M. G., Tran, L. E., Bai, X., Allayous, C., Provent-Roy, S., Indini, A., Bhave, P., Farid, M., Kähler, K. C., … Long, G. V. (2022). Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study. Annals of Oncology, 33(9), 968–980. https://doi.org/10.1016/j.annonc.2022.06.004

Ricciuti, B., Wang, X., Alessi, J. V., Rizvi, H., Mahadevan, N. R., Li, Y. Y., Polio, A., Lindsay, J., Umeton, R., Sinha, R., Vokes, N. I., Recondo, G., Lamberti, G., Lawrence, M., Vaz, V. R., Leonardi, G. C., Plodkowski, A. J., Gupta, H., Cherniack, A. D., … Awad, M. M. (2022). Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. JAMA Oncology, 8(8), 1160. https://doi.org/10.1001/jamaoncol.2022.1981

Bailey, S., Wang, Q., Kong, C. Y., Stone, K., Veluswamy, R., Bates, S. E., Smith, C. B., Wisnivesky, J. P., & Sigel, K. (2022). Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbidities. Current Problems in Cancer, 46(4), 100867. https://doi.org/10.1016/j.currproblcancer.2022.100867

Bansal, A., Saleh-E-In, Md. M., Kar, P., Roy, A., & Sharma, N. R. (2022). Synthesis of Carvacrol Derivatives as Potential New Anticancer Agent against Lung Cancer. Molecules, 27(14), 4597. https://doi.org/10.3390/molecules27144597

Henick, B. S., Villarroel-Espindola, F., Datar, I., Sanmamed, M. F., Yu, J., Desai, S., Li, A., Aguirre-Ducler, A., Syrigos, K., Rimm, D. L., Chen, L., Herbst, R. S., & Schalper, K. A. (2022). Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer, 10(7), e005025. https://doi.org/10.1136/jitc-2022-005025

Govindan, R., Aggarwal, C., Antonia, S. J., Davies, M., Dubinett, S. M., Ferris, A., Forde, P. M., Garon, E. B., Goldberg, S. B., Hassan, R., Hellmann, M. D., Hirsch, F. R., Johnson, M. L., Malik, S., Morgensztern, D., Neal, J. W., Patel, J. D., Rimm, D. L., Sagorsky, S., … Herbst, R. S. (2022). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma. Journal for ImmunoTherapy of Cancer, 10(5), e003956. https://doi.org/10.1136/jitc-2021-003956

Lu, L., Zhang, Y., Chen, C., Field, R. W., & Kahe, K. (2022). Radon exposure and risk of cerebrovascular disease: a systematic review and meta-analysis in occupational and general population studies. Environmental Science and Pollution Research, 29(30), 45031–45043. https://doi.org/10.1007/s11356-022-20241-x

Biswas, A. K., Han, S., Tai, Y., Ma, W., Coker, C., Quinn, S. A., Shakri, A. R., Zhong, T. J., Scholze, H., Lagos, G. G., Mela, A., Manova-Todorova, K., de Stanchina, E., Ferrando, A. A., Mendelsohn, C., Canoll, P., Yu, H. A., Paik, P. K., Saqi, A., … Acharyya, S. (2022). Targeting S100A9–ALDH1A1–Retinoic Acid Signaling to Suppress Brain Relapse inEGFR-Mutant Lung Cancer. Cancer Discovery, 12(4), 1002–1021. https://doi.org/10.1158/2159-8290.cd-21-0910

Wang, F., Liu, Y., Qiu, W., Shum, E., Feng, M., Zhao, D., Zheng, D., Borczuk, A., Cheng, H., & Halmos, B. (2022). Functional Analysis of MET Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination. Cancer Research, 82(7), 1365–1379. https://doi.org/10.1158/0008-5472.can-21-1327

Olazagasti, C., Ehrlich, M., Kohn, N., Aviles, K., Hoilett, A., & Seetharamu, N. (2022). Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer. Cancer Control, 29. https://doi.org/10.1177/10732748221077959

Capaccione, K. M., Huang, S., Toor, Z., May, B., Deng, A., & Salvatore, M. M. (2022). Immunotherapy related pericardial effusion on chest CT. Clinical Imaging, 82, 204–209. https://doi.org/10.1016/j.clinimag.2021.11.029

Yoon, J. H., Sun, S. H., Xiao, M., Yang, H., Lu, L., Li, Y., Schwartz, L. H., & Zhao, B. (2021). Convolutional Neural Network Addresses the Confounding Impact of CT Reconstruction Kernels on Radiomics Studies. Tomography, 7(4), 877–892. https://doi.org/10.3390/tomography7040074